At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Radiofrequency Ablation (device)
- How long the study runs
- Study runs about 143 months (dates as stated)
- About the drug or intervention
- Radiofrequency Ablation — device: Radiofrequency Ablation used in the central nervous system (CNS) in functional neurosurgery
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 200
- Started
- 2024-01-29
- Last checked
- 2026-09
Plain English Summary
What is this study?
- • Testing a new treatment for parkinson disease
- • Clinical study - 200 participants
- • The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery
Who can take part?
- • Adults
- • Diagnosed with parkinson disease
Where?
- • London - St. Georges Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
More detail
The objective of this study is to compile real-world outcomes of Boston Scientific Corporation commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain or for...
- ✓Signed a valid, IRB/EC/REB-approved agreement to take part form
Who cannot take part
- ✗Meets any contraindications per locally applicable Directions for Use (DFU)
- ✗Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's...
See the full criteria
Where Is This Study? (1 UK site)
St. Georges Hospital
London, United Kingdom
How to Get in Touch
Stephanie Delvaux
Sponsor contactCONTACT
Diane Keesey
Sponsor contactCONTACT